Edition:
United Kingdom

Audentes Therapeutics Inc (BOLD.OQ)

BOLD.OQ on NASDAQ Stock Exchange Global Market

37.57USD
4:52pm BST
Change (% chg)

$0.17 (+0.45%)
Prev Close
$37.40
Open
$37.48
Day's High
$38.20
Day's Low
$37.11
Volume
18,301
Avg. Vol
155,339
52-wk High
$42.48
52-wk Low
$18.00

About

Audentes Therapeutics, Inc. is an early-stage biotechnology company. The Company is focused on developing and commercializing gene therapy products for patients suffering from serious, life-threatening rare diseases caused by single gene defects. The Company has a portfolio of product candidates, including AT132 for the... (more)

Overall

Beta: --
Market Cap(Mil.): $722.67
Shares Outstanding(Mil.): 27.78
Dividend: --
Yield (%): --

Financials

  BOLD.OQ Industry Sector
P/E (TTM): -- 69.29 32.55
EPS (TTM): -3.54 -- --
ROI: -57.99 8.90 13.82
ROE: -145.70 10.04 15.24

Earnings vs. Estimates